WEIFANG, SHANDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- 1. Rising Global Demand for PDT LED Light Therapy As ...
Photodynamic therapy (PDT) — a treatment most commonly thought of for field cancerization — is an effective tool for reducing rhytides and lentigines, results from a small prospective study showed.
WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today the ...
Tsukuba, Japan—In Japan, cancer has been the leading cause of death since 1981. At present, surgery, chemotherapy, and radiotherapy are the main treatment options. However, these treatments ...
Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz ...
Prognostic factors in elderly patients with grade 3 gliomas. Background: Usual treatment of brain tumors includes surgery, radiotherapy and chemotherapy, but the general prognosis is bad, with local ...
Photodynamic therapy using TLD-1433 represents a viable treatment option for BCG-unresponsive NMIBC CIS with an acceptable safety profile. Light-activated TLD-1433 photodynamic therapy (PDT) may be a ...
WOBURN, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results